肺积1号方抑制la-795肺腺癌小鼠移植瘤生长的实验研究 |
| |
引用本文: | 贺珊珊,庄静,杨静,孙长岗.肺积1号方抑制la-795肺腺癌小鼠移植瘤生长的实验研究[J].预防医学文献信息,2010(12):1169-1170. |
| |
作者姓名: | 贺珊珊 庄静 杨静 孙长岗 |
| |
作者单位: | [1]潍坊医学院临床学院研究生处,山东潍坊261041 [2]潍坊市中医院肿瘤科,山东潍坊261041 |
| |
摘 要: | 目的]探讨肺积1号方对la-795肺腺癌小鼠移植瘤生长的抑制作用。方法]给40只T739小鼠腋下注射肿瘤组织匀浆复制la-795小鼠肺癌模型,接种24 h后,按随机数字表法,将40只小鼠完全随机分为4组,每组10只,开始给药,4组分别为:对照组、顺铂DDP组、肺积1号方组、DDP+肺积1号方组,观察各组小鼠一般状况、肿瘤大小、计算抑瘤率。结果]肺积1号方组小鼠体重增加最多,与对照组比较,差异有统计学意义(P〈0.01),优于DDP组(P〈0.05);各治疗组瘤重均显著低于对照组,抑瘤率DDP组、肺积1号方组、DDP+肺积1号方组与对照组比较,差异有统计学意义(P〈0.01),与DDP组比较,DDP+肺积1号方组效果更好(P〈0.05)。肺积1号方与DDP合用有明显增效作用,抑瘤率大于单用DDP组。结论]肺积1号方能够明显抑制la-795肺腺癌小鼠移植瘤的生长,与DDP合用有明显增效作用。
|
关 键 词: | 肺积1号方 la-795 肺癌 |
Experiment on Tumor Inhibition with Feiji-1 Therapy in Mice with la-795 Lung Cancer |
| |
Institution: | HE Shan-shan,ZHUANG Jing,YANG Jing,et al.(Post-graduates Division of Weifang Medical College,Weifang,261041,Shandong,China) |
| |
Abstract: | Objective] To investigate the anti-tumor effect of Feiji-1 therapy in mice with la-795 lung cancer.Methods]40 T739 mice under the regular injections of the organization of the replication la-795 mouse lung cancer model.After 24 hours,at random digital watch,40 mice were randomly divided into four groups,each group of 10,and began to take medicine:the control group,Cisplatin(DDP) group,Feiji-1 group and Feiji-1 with DDP group.General position was observed,the tumor size and detected tumor inhibition rates of the mice in each group.Results]There was a statistical significance between Feiji-1 group and the control group on gaining weight(P0.01),and it was better than DDP group(compared with the control group,P0.05);Compared with the control group,there were significant deviations in tumor inhibition rates of the mice in other three groups(P0.01).Compared with DDP group,there was significant deviation in Feiji-1 with DDP group(P0.05).Conclusion]Feiji-1 has certain inhibitive effect on the growth of la-795 lung cancer,enhancing the effect when it is used together with DDP. |
| |
Keywords: | Feiji-1 La-795 Lung cancer |
本文献已被 维普 等数据库收录! |
|